English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52746927    Online Users :  677
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"wei yu liao"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 41-50 of 133  (14 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-07-21T06:09:09Z Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib Chih-Hsin Yang J.; Yu C.-J.; Ho C.-C.;Wei-Yu Liao;Lin C.-A.;Shih J.-Y.;Yu C.-J.;Chih-Hsin Yang J.; Ho C.-C.; WEI-YU LIAO; Lin C.-A.; Shih J.-Y.
臺大學術典藏 2020-07-21T06:09:09Z Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer – A multicenter retrospective SEQUENCE study Hsieh M.-J.; Wu W.-S.; Chen Y.-M.; Tsai Y.-H.; Hsia T.-C.; Tu C.-Y.; Lin M.-C.; WEI-YU LIAO; Liu C.-Y.; Chen K.-C.; Yang T.-Y.; Tseng J.-S.; Hsu K.-H.; Yu C.-J.; Yang C.-T.; Tseng C.-H.; Chang G.-C.; Chang G.-C.;Tseng C.-H.;Hsu K.-H.;Yu C.-J.;Yang C.-T.;Chen K.-C.;Yang T.-Y.;Tseng J.-S.;Liu C.-Y.;Wei-Yu Liao;Hsia T.-C.;Tu C.-Y.;Lin M.-C.;Tsai Y.-H.;Hsieh M.-J.;Wu W.-S.;Chen Y.-M.
臺大學術典藏 2020-07-21T06:09:08Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Wei-Yu Liao;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; WEI-YU LIAO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏 2020-07-21T06:09:07Z Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery Hsu F.-M.; Yang P.-C.; Yang W.-C.;Xiao F.;Shih J.-Y.;Ho C.-C.;Chen Y.-F.;Tseng H.-M.;Chen K.-Y.;Wei-Yu Liao;Yu C.-J.;Yang J.C.-H.;Kuo S.-H.;Cheng J.C.-H.;Yang P.-C.;Hsu F.-M.; Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; WEI-YU LIAO; Yu C.-J.; Yang J.C.-H.; Cheng J.C.-H.; Kuo S.-H.
臺大學術典藏 2020-07-21T06:09:06Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang S.-K.;Lee M.-R.;Wei-Yu Liao;Ho C.-C.;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Lee M.-R.; WEI-YU LIAO; Ho C.-C.; Ko J.-C.; Shih J.-Y.
臺大學術典藏 2020-07-21T06:09:06Z Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum Shih J.-Y.; Yu C.-J.; Chen K.-Y.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Wei-Yu Liao;Ho C.-C.;Tsai T.-H.;Chen K.-Y.;Shih J.-Y.;Yu C.-J.
臺大學術典藏 2020-07-21T06:09:06Z Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients Shih J.-Y.; Ho C.-C.; Wu T.-H.;Hsiue E.H.-C.;Lee J.-H.;Lin C.-C.;Wei-Yu Liao;Ho C.-C.;Shih J.-Y.;Yu C.-J.;Yang J.C.-H.; Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; WEI-YU LIAO; Yu C.-J.; Yang J.C.-H.
臺大學術典藏 2020-07-21T06:09:05Z The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer Yu K.-L.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Lin C.-K.; Hsu C.-L.; Shih J.-Y.; Yu K.-L.;Tsai T.-H.;Ho C.-C.;Wei-Yu Liao;Lin C.-K.;Hsu C.-L.;Shih J.-Y.
臺大學術典藏 2020-07-21T06:09:04Z Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinoma Yu C.-J.; Shih J.-Y.; WEI-YU LIAO; Hsieh M.-S.; Yang C.-Y.
臺大學術典藏 2020-07-21T06:09:04Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Yu C.-J.; Shih J.-Y.; Yang J.C.-H.; Lin Z.-Z.; Lee J.-H.; Chen K.-Y.; Yang C.-Y.; Hsu C.-L.; Ho C.-C.; WEI-YU LIAO; Chen J.-S.; Lin Y.-T.

Showing items 41-50 of 133  (14 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page